The Financial Express
 
 
 
 

 

 
   INVESTOR
Tuesday, December 04, 2001 

UTI mulls converting equity holding in Infosys into ADRs

Bangalore, Dec 3: Unit Trust of India (UTI) on Monday indicated it is mulling converting its equity holding in software major Infosys Technologies into American Depository Receipts (ADRs) to offload them in international markets.


We have not been contacted so far, says Narayana Murthy
New Delhi, Dec 3: UTI has not yet approached Infosys with any proposal to convert its entire equity holding in the IT company into ADRs for offloading them in international markets. “UTI has not yet contacted us on any such proposal,” Infosys chief NR Narayana Murthy said here. Asked what would be Infosys’ views if it received any communication from UTI on the subject of conversion of equity into ADRs, Mr Narayana Murthy said “There is an entire procedure involved in such plans, including getting government approval. Then the shareholders would have to meet and give their approval, or views.” On October 10, the board of directors of the company declared an interim dividend of Rs 7.50 per share (par value Rs 5 each).On the same day the company had said that it was on course to meet revenue and earnings target for the third quarter and current fiscal. — PTI

“Nothing has happened till now. But the thinking process has started. No idea how long it will take,” Madhav Kumar, UTI general manager (business development and marketing) told reporters here on Monday.

Mr Kumar was reacting to a query on a reported proposal by UTI to approach Infosys to convert its equity holding into ADRs in a move seen as aimed at realising a much higher value as Infosys ADRs were quoting at about a 70-per cent premium to the domestic price.

However, Infosys chairman NR Narayana Murthy said that UTI has not yet contacted the company on “any such proposal.” According to an Infosys spokesman in Bangalore, UTI currently holds 5.7-per cent equity in Infosys, which translates to 37,72,035 shares.

The Nasdaq-listed Infosys had reported a 30.87-per cent rise in its net profit at Rs 201.56 crore for the quarter ended September.

Mr Kumar asserted that investors’ confidence had not been shaken in US-64, UTI’s flagship scheme, whose fiasco had stirred up a major controversy. “Out of an investment of Rs 13,000 crore, only Rs 317 crore had been redeemed,” Mr Kumar said.

— PTI

 

 
Write to the Editor
Mail this story
Print this story
 
 
 
   
 
About Us | Advertise With Us | Privacy Policy | Feedback
© 2001: Indian Express Newspapers (Bombay) Ltd. All rights reserved throughout the world.